We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
METHOTREXATE AN OLD DRUG WITH NEW TRICKS.
- Authors
Rofaeil, Remon R.; Ibrahim, Mohamed A.; Mohyeldin, Reham H.; Abdelzaher, Walaa Y.
- Abstract
Methotrexate (MTX) is the first line drug for the treatment of a number of rheumatic and non-rheumatic disorders. It is currently used as an anchor disease, modifying anti-rheumatic drug in the treatment of rheumatoid arthritis (RA). Despite the development of numerous new targeted therapies, MTX remains the backbone of RA therapy due to its potent efficacy and tolerability. There has been also a growing interest in the use of MTX in the treatment of chronic viral mediated arthritis. Many viruses—including old world alphaviruses, Parvovirus B19, hepatitis B/C virus, and human immunodeficiency virus—have been associated with arthritogenic diseases and reminiscent of RA. MTX may provide benefits although with the potential risk of attenuating patients’ immune surveillance capacities. In this review.
- Subjects
INFECTIOUS arthritis; METHOTREXATE; HIV; PARVOVIRUS B19; RHEUMATOID arthritis
- Publication
Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2021, Vol 12, Issue 3, p2277
- ISSN
0975-3583
- Publication type
Article